Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/12083
Title: Novel regulation mechanism of adrenal cortisol and DHEA biosynthesis via the endogen ERAD inhibitor small VCP-interacting protein
Authors: İlhan, Recep
Üner, Göklem
Yılmaz, Sinem
Atalay Sahar, Esra
Çaylı, Sevil
Erzurumlu, Yalçın
Gözen, Oğuz
Ballar Kırmızıbayrak, Petek
Ege Üniversitesi
Izmir Institute of Technology
Ege Üniversitesi
Ege Üniversitesi
Ankara Yıldırım Beyazıt Üniversitesi
Ege Üniversitesi
Ege Üniversitesi
Ege Üniversitesi
Keywords: ERAD
Proteins
DHEA biosynthesis
Issue Date: Dec-2022
Publisher: Nature Publishing Group
Abstract: Endoplasmic reticulum-associated degradation (ERAD) is a well-characterized mechanism of protein quality control by removal of misfolded or unfolded proteins. The tight regulation of ERAD is critical for protein homeostasis as well as lipid metabolism. Although the mechanism is complex, all ERAD branches converge on p97/VCP, a key protein in the retrotranslocation step. The multifunctionality of p97/VCP relies on its multiple binding partners, one of which is the endogenous ERAD inhibitor, SVIP (small VCP-interacting protein). As SVIP is a promising target for the regulation of ERAD, we aimed to assess its novel physiological roles. We revealed that SVIP is highly expressed in the rat adrenal gland, especially in the cortex region, at a consistently high level during postnatal development, unlike the gradual increase in expression seen in developing nerves. Steroidogenic stimulators caused a decrease in SVIP mRNA expression and increase in SVIP protein degradation in human adrenocortical H295R cells. Interestingly, silencing of SVIP diminished cortisol secretion along with downregulation of steroidogenic enzymes and proteins involved in cholesterol uptake and cholesterol biosynthesis. A certain degree of SVIP overexpression mainly increased the biosynthesis of cortisol as well as DHEA by enhancing the expression of key steroidogenic proteins, whereas exaggerated overexpression led to apoptosis, phosphorylation of eIF2α, and diminished adrenal steroid hormone biosynthesis. In conclusion, SVIP is a novel regulator of adrenal cortisol and DHEA biosynthesis, suggesting that alterations in SVIP expression levels may be involved in the deregulation of steroidogenic stimulator signaling and abnormal adrenal hormone secretion.
Description: This research was funded by the Scientific and Technological Research Council of Turkey (TUBITAK, SBAG-116S444) and by Ege University internal funds (16/ECZ/006). We thank the Pharmaceutical Sciences Research Centre (FABAL, Ege University, Faculty of Pharmacy) and Biotechnology and Bioengineering Application and Research Centre (BIYOMER, İzmir Institute of Technology) for equipment support, Burcu ERBAYKENT TEPE-DELEN, Selin GÜNAL, and Aysegül KAYMAK for their technical assistance and scientific support.
URI: https://doi.org/10.1038/s41598-022-04821-y
https://hdl.handle.net/11147/12083
Appears in Collections:Bioengineering / Biyomühendislik
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File Description SizeFormat 
s41598-022-04821-y.pdfArticle (Makale)3.28 MBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

6
checked on Feb 16, 2024

WEB OF SCIENCETM
Citations

5
checked on Jan 27, 2024

Page view(s)

20,128
checked on Feb 26, 2024

Download(s)

632
checked on Feb 26, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.